This review focuses on Indian Herbal drugs and plants used in the treatment of diabetes, especially in India. Diabetes is an important human ailment afflicting many from various walks of life in different countries. diabetes is one of the major causes of death and disability in the world. Natural products from medicinal plants, either as pure compounds or as standardized extracts, provide unlimited opportunities for new drug leads because of the unmatched availability of chemical diversity. Due to an increasing demand for chemical diversity in screening programs, seeking therapeutic drugs from natural products, interest particularly in edible plants has grown throughout the world. Botanicals and herbal preparations for medicinal usage contain various types of bioactive compounds. Phytochemicals identified from medicinal plants present an exciting opportunity for the development of new types of therapeutics for diabetes mellitus. Most prevalent among phytochemical groups are the alkaloids, glycosides, polysaccharides, and phenolics such as flavonoids, terpenoids and steroids. 
INTRODUCTION
"In the light of this knowledge,
There is no substance in this world
May not be used as medicine in This or that manner, And for this or that purpose" Nature always stands as a golden mark to exemplify the outstanding phenomenon of symbiosis .the plant are in dispersible to man for his life .a large portion of the Indian population even today depends on the Indian system of medicine-Ayurveda ''an ancient science of life '' 1 According to the World Health Organization (WHO), more than 80% of the world's population relies on traditional medicine for their primary healthcare needs.
The use of herbal medicines in Asia represents a long history of human interactions with the environment. 2 These plants have no side effects and many existing medicines are derived from the plants. The purpose of this systematic review is to study diabetes and to summarize the available treatments for this disease, focusing especially on herbal medicine. 3 Diabetes is a lifelong (chronic) disease and is a group of metabolic disorders characterized by high levels of sugar in blood (hyperglycemia) 4 . More than 230 million people worldwide are affected, and it is expected to reach 350 million by 2025. Globally the affected people are unaware of the disease and only half receive adequate treatment 5 . It is caused due to deficiency of insulin or resistance to insulin or both. Insulin is secreted by β-cells of pancreas to control blood sugar levels 4. Blurry visions, excess thirst, fatigue, frequent
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Types
Diabetes results in the impairment of the body's ability to use food because either the pancreas does not make insulin or the body cannot use insulin properly. Hypoglycemia (low blood glucose) is most commonly seen in diabetic patients, when the body gets too much insulin, too little food, a delayed meal, or more than the usual amount of exercise. When the body gets too little insulin, too much food, or too little exercise, it results in hyperglycemia (high blood glucose) 7,8. Stress may contribute to hyperglycemia. Hyperglycemic state (diabetes mellitus) arises when the blood glucose (sugar) levels are higher than 180 mg/dl (10 mmol/l) 9 .
Diabetes is of mainly three types. They are type-1 diabetes (T1D), type-2 diabetes (T2D) and gestational diabetes mellitus. T1D, also called as the insulindependent diabetes mellitus (IDDM), manifests due to the autoimmune damage of the β-cells which then leads to the suppression or cessation of insulin production. T1D is also called the "juvenile diabetes". T2D, also called as the adult-onset diabetes or non-insulindependent diabetes mellitus (NIDDM) among humans is caused by either low levels or absence of insulin or insulin resistance (IR) 9. Gestational diabetes mellitus (GDM) is defined as glucose intolerance of varying degrees, which appears, or is first diagnosed, during pregnancy and may or may not persist after delivery 10, 11 .
Potential Anti diabetic medicinal plant reported from India: Antidiabetic principle from traditional medicinal plants. Many compounds isolated from plant sources have been reported to show antidiabetic activity. The table summarizes some recent information in the field of antidiabetic phytochemicals Many kinds of natural products, such as terpenoids, alkaloids, flavonoids, phenolics, and some others, have shown antidiabetic potential. Particularly, schulzeines A, B, and C, radicamines A and B, 2,5-imino-1,2,5-trideoxy-Lglucitol, betahomofuconojirimycin, myrciacitrin IV, dehydrotrametenolic acid, corosolic acid (Glucosol), 4 -(alpha-rhamnopyranosyl) ellagic acid, and 1,2,3,4,6-pentagalloylglucose have shown significant antidiabetic activities. 12 Oral administration of onion (A. cepa L.) and garlic (A. sativum L.) to alloxan-induced diabetic rats for 30 days ameliorated hyperglycemia, reversed weight loss and depletion of liver glycogen. The anti-diabetic bioactive principles of A. cepa L. and A. sativum L. were Smethylcysteinesulfoxide (SMCS) and Sallylcysteinesulfoxide (SACS) respectively. The studies showed that SMCS and SACS exerted their anti-diabetic properties by stimulating insulin secretion as well as compete with insulin for insulin inactivating sites in the liver. Specifically, SACS inhibited gluconeogenesis in the liver. In addition, SACS from A. sativum L impeded lipid peroxidation due to its antioxidant and secretagogue actions. The capacities of A. cepa L. and A. sativum L. to alleviate DM in the experimental rats were comparable with diabetic rats treated with glibenclamide and insulin. The study also noted that SMCS and SACS caused significant increase in the biosynthesis of cholesterol from acetate in the liver, which was an
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Aloe vera (Aloe barbedensis); Aspholedeceae
13
A 1.0 μg of five phytosterols-lophenol, 24-methyllophenol, 24-ethyl-lophenol, cycloartanol, and 24-methylene-cycloartanol from A. vera exhibited comparable capacities to lower blood glucose levels in Type II diabetic BKS.Cg-m+/+Lepr db/J (db/db) mice following 28 day treatment. The five phytosterols caused significant decrease in blood HbA1c levels by 15-18%. Additionally, severe diabetic mice treated with the five phytosterols did not suffer weight loss because of rapid excretion of glucose in the urine. The findings suggested that phytosterols derived from A. vera gel have a long-term blood glucose lowering effect, which could be applied as agents of glycemic control in Type 2 DM. Studies showed thatphytosterols stimulate the biosynthesis and/or release of insulin as well as alter the activity of carbohydrate metabolizing enzymes.
Catharanthus roseus [L.] G. Don; Apocynaceae 14
The Madagascar periwinkle (C. roseus), is a traditional remedy and was marketed in England as 'Vinculin' for the treatment of DM. Earlier studies showed that leaf aqueous extracts of C. roseus administered orally to rabbits and dogs caused hypoglycemic response. Similar studies using variety of laboratory animals and limited clinical trials gave negative or at best equivocal results. Alkaloids, notably, catharanthine 17 , leurosine 18 , lochnerine 19 , tetrahydroalstonine 20 , vindoline 21 , and vindolinine 22 are the major anti-diabetic principles present in C. roseus. Specifically, studies showed that vincamine 23 and (-)-eburnamonine 24 caused extensive decrease in rat brain tissue glucose concentration, with concomitant increase in lactate and pyruvate concentrations as well as the lactate pyruvate ratio and increase in tissue ATP contents. In vitro studies showed that the quinoline derivatives, quinolate and 3-mercaptopicolinate, inhibited hepatic gluconeogenesis from lactate or alanine by inhibiting muscle cytosolic/ mitochondrial phosphoenolpyruvate carboxykinase and cytosolic aspartate aminotransferase activities. Certainly the active alkaloids analogs of C. roseus exhibited oral hypoglycemic activity of one third capacities when compared with tolbutamide.
Oral administration of dichloromethane:methanol (1:1) leaf and twig extracts of C. roseus at dose = 500 mg/kg to streptozotocin (STZ)-induced diabetic rats for 7 and 15 days gave 48.6 and 57.6% hypoglycemic activity, respectively. The same dose for 30 days exhibited protective effect against STZ challenge. The antidiabetic action of C. roseus was as a result of inhibition of hepatic glycogen synthase, glucose 6-phosphatedehydrogenase, succinate dehydrogenase and malate dehydrogenase activities coupled with increased mobilization of glucose following treatment of the experimental rats. Similarly, the same dose of C. roseus extracts ameliorated oxidative stress as exemplified by lower levels of 2-thiobarbituric acid reactive substances (TBARS) in diabetic rats following treatment.
Cinnamomum cassie (Chinese cinnamon); Lauraceae 15 Cinnamon methylhydroxychalcone polymer (MHCP) from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes. Therefore, MHCP may be useful in the treatment of Type II DM and in the study of the pathways leading to glucose utilization in peripheral cells.
Coccinia indica; cucurbibaceae 16, 17 Orally administered pectin materials isolated from fruit extracts of C. indica at dose = 200 mg/100 g body weight/day caused hypoglycemia in normal rats. The study noted that pectin materials caused significant reduction in blood glucose and an increase in the liver glycogen as a result of increase in hepatic glycogen synthetase activity and corresponding reduction in phosphorylase activity. Hypoglycemic effect of ethanolic extract of C. indica is partly due to the repression of the key gluconeogenic enzyme (glucose-6-phosphatase), but did not affect alanine aminotransferase and aspartate amino transferase activities, in starved male rats.
Fiscus bengalensis; Moraceae
18
Leucopelargonidin-3-0-alpha-L rhamnoside from dimethoxy ether extract of Indian Banyan tree F. bengalensis Linn bark at a medium effective dose = 100 mg/kg caused hypoglycemia and increased blood insulin levels in normal and moderately alloxan-induced diabetic dogs following two hours oral administration. The bioactive glycoside stimulated insulin secretion in the experimental animals. Furthermore, acute (doses = 0.2-1.8 g/kg) administration to mice and chronic (doses = 100, 250 and 500 mg/kg) daily administration to rats for a period of one month respectively did not elicit toxic effects even at the high dose of 1.8 g/kg in experimental animals.
Gymmema slyvestre (Gurnar); Asclepiadaceae 18
G. sylvestre extracts at various doses caused decreased blood sugar level in STZ-induced diabetic rat models, which was comparable with the standard anti-diabetic drug-tolbutamide. Also, human experiments showed that GS4 (dose = 400 mg/day), a water-soluble extract from leaves of G. sylvestre, administered to patients suffering from insulindependent diabetes mellitus (IDDM) and placed on insulin therapy, caused the normalization of their serum lipid profiles, whereas insulin requirements together with fasting blood glucose and glycosylated haemoglobin (HbA lc ) and other glycosylated plasma protein levels remained higher than that of the control subjects. Nevertheless, GS4 therapy appears to enhance endogenous insulin biosynthesis, possibly by regeneration/revitalization of the residual β-cells of IDDM individuals.
Ginseng (Panax ginseng); Araliaceae and Fenugreek (Trigonella foenum-graecum L.) 19 In vivo experiments using STZ-induced diabetic rats chronically administered with food mixed with steroid saponins from the seeds of fenugreek (T. foenumgraecum L) (dose = 12.5 mg/300 g body weight per day) showed significantly increase in food intake as well as the motivation to eat in normal rats. it also stabilized the
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Momordica cymbalaria (Bitter Melon); Cucurbiteae 20
Oral and intra-peritoneal administration of aqueous fruit extracts of M. charantia to normal rats lowered the glycemic response without altering the insulin response. Also, aqueous extract and the residue after alkaline chloroform extraction reduced hyperglycemia in diabetic mice after 1 hour. The recovered plant matters by acid water wash of the chloroform extract following alkaline water wash engendered a slower hypoglycemic effect. These findings suggested that orally administered M. charantia extracts lower glucose concentrations independently of intestinal glucose absorption and involved an extra-pancreatic effect.
In another study, M. cymbalaria fruit powder caused reduction in blood sugar concentrations in alloxaninduced diabetic rats following 15 days treatment. Elevated serum cholesterol and triglycerides levels were lowered with significant improvement in hepatic glycogen level in treated diabetic rats. The study showed the anti-diabetic and hypolipidemic properties of M. cymbalaria fruit powder.
Muurrayi komingii (Cury leaf); Rutaceae
20
A single oral administration of aqueous leaf extracts of M. koenigii (doses = 200, 300 and 400 mg/kg) lowered blood glucose level in normal and alloxan-induced diabetic rabbits. The reduction on blood glucose levels in normal and mild diabetic rabbits corresponded to 14.68% and 27.96% following 4 hours of oral administration of 300 mg/ kg of the leaf extract. Likewise, 300 mg/kg of the leaf extract caused a marked improvement in glucose tolerance by 46.25% in subdiabetic and 38.5% in mild diabetic rabbits at 2 hours post prandial test. The study suggested that the aqueous leaf extracts of M. koenigii may be prescribed as adjunct to dietary therapy and treatment of DM. Aegle marmelos possess anti-diabetic and hypolipidemic effects in diabetic rats. 
Polygala senega; Polygalaceae
21
The triterpenoid glycoside-Senegin-II and saponins are the main anti-diabetic components of P. senega (L.). Study showed that n-butanol extract of P. senega rhizomes (SN) (dose = 5.0 mg/kg) caused reduction in the blood glucose of normal and KK-Ay mice following 4 hours intra-peritoneal administration. However, STZinduced diabetic mice did not experience significant change in the blood glucose following the administration of SN. The study proposed that the hypoglycemic effect of SN occurs without altering plasma insulin concentration.
Syzigium cumini (Eugenia janbolaria); Mytaceae
22
At the dose levels of 200 and 400 mg/kg, ethyl acetate and methanol extracts of S. cumini (Myrtaceae) seed exhibited significant antiinflammatory activity in carrageenan induced paw edema in Wistar rats. This anti-inflammatory activity of the plant extract could be of therapeutic benefit by ameliorating increased inflammatory response associated with DM.
Trigonella foemum-graecum (Fenugreek) 23 T. foenum-graecum (Fenugreek) seeds fraction (dose = 0·5 g/ kg body weight) significantly exerted glycemic control in normal, Type I or Type II diabetic rats. The soluble dietary fibre (SDF) fraction controlled elevation of blood glucose after oral ingestion of sucrose in normal and Type II diabetic rats. Intestinal disaccharides activity and glucose absorption were sufficiently suppressed, whereas gastrointestinal motility increased following treatment of the rats with SDF fraction. Daily oral administration of SDF to Type II diabetic rats for 28 days caused decreased serum glucose level but increased liver glycogen content with enhanced total antioxidant status. Serum insulin and insulin secretion were not affected by the SDF fraction. Overall, T. foenum-graecum seed extracts enhanced glucose transport in 3T3-L1 adipocytes as well as increased insulin sensitivity. Therefore, SDF fraction of T. foenum-graecum seeds exerted anti-diabetic effects through inhibition of carbohydrate digestion and absorption, and enhancement of peripheral insulin action.
Large classes of compounds are available from many plant sources. Natural products such as plant extracts, phytochemicals, and microbial metabolites are currently studied for their potential uses in the treatment and prevention of diabetes mellitus. A number of plant extracts and natural biomolecules have shown very promising effects indicating that the dietary intake of phytochemicals could be a promising strategy for diabetes prevention . for the reduction of the risk of the disease. Therapies based on phytochemicals therefore constitute a novel pharmacological approach for treatment or an approach that would reinforce existing treatments.
CONCLUSION
From the above stud it was concluded that the most common disadvantage of using synthetic drugs is their serious side effects. This led to the use of medicines which have less/no side effects i.e., herbal medicines. 
